Researchers at the University of Notre Dame have discovered a way to make influenza visible to the naked eye, according to a new study in the Journal of the American Chemical Society.
By engineering dye molecules to target a specific enzyme of the virus, the team was able to develop a test kit that emitted fluorescent light when illuminated with a hand-held lamp or blue laser pointer.
Scientists used test samples that mimicked that of an infected patient, and spiked the samples with the enzyme, called neuraminidase, which had been purified from flu virus. The samples emit red fluorescent light as a positive indication of the influenza virus. Blue fluorescent light signals a negative result. The same process also allowed scientists to determine which of two approved antiviral drugs would be a better treatment option for the individual patient.
While still a prototype, researchers believe that with optimization the diagnostic could be developed to be used in point of care clinics or the home environment for a rapid, easy to interpret test for the presence of influenza.
“Viral cultures are the gold standard for diagnosis of influenza but take several days to develop. By targeting an enzyme inherent to the virus and identifying its presence in a sample, we can make a rapid determination of the influenza in a patient for an efficient and immediate diagnostic that would improve patient treatment and reduce overuse of antivirals,” said Bradley Smith, Emil T. Hofman Professor of Chemistry and Biochemistry in the Department of Chemistry and Biochemistry, director of the Notre Dame Integrated Imaging Facility and co-author of the study.
Smith and his team created a new method to detect neuraminidase, which is located on the surface of the virus. Researchers began by designing a dye molecule to emit red fluorescent light when it interacts with the neuraminidase. Following validation of enzyme recognition, researchers then tested the dye with two antiviral drugs used to treat influenza — Zanamivir, also known as Relenza, and Oseltamivir, known widely as Tamiflu. The antivirals are neuraminidase inhibitors. Samples containing dye and neuraminidase were combined with each of the antivirals and illuminated. Red fluorescence indicated the enzyme was still active, meaning the antiviral failed to inhibit the virus in that patient. Blue light indicated the enzyme had been blocked, presenting an effective treatment option.
The study, which received funding from the National Science Foundation and Notre Dame’s research initiative, Advanced Diagnostics and Therapeutics, focused specifically on fluorescence detection of the virus and efficacy of the two inhibitors. Smith’s team hopes to build upon these results in the future.
The Latest on: Influenza diagnostic
- James Paxton returns to the Mariners, but still feeling the effects of influenza and pneumonia on September 17, 2018 at 3:23 pm
This isn’t an official diagnosis by Paxton or the medical staff, but he had “Flu-monia” “The doctor said it was influenza with pneumonia to go with it,” Paxton said. “It was both.” Pete Carroll says S... […]
- Wisconsin Veterinary Diagnostic Lab has new director, new direction on September 7, 2018 at 11:23 am
The Wisconsin Veterinary Diagnostic Laboratory (WVDL ... WVDL also supports the state’s poultry industry by helping respond to outbreaks of avian influenza, participating in the federal Salmonella Act... […]
- Global Rapid Influenza Diagnostic Tests Market Forecast to 2025 – Detailed Analysis by Types & Applications on September 1, 2018 at 5:00 pm
The global Rapid Influenza Diagnostic Tests market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2018 and 2025. Globa... […]
- Rapid Influenza Diagnostic Test (RIDT) Market Size, Growth, Regional Outlook, Forecast, Application Analysis To 2025 on August 24, 2018 at 7:52 am
This research report categorizes the global Rapid Influenza Diagnostic Test (RIDT) market by top players/brands, region, type and end user. This report also studies the global Rapid Influenza Diagnost... […]
- Global Influenza Diagnostic Equipment Market Huge Growth Opportunities, Trends and Forecast to 2025 - QY Research, Inc. on August 23, 2018 at 2:54 am
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods ... […]
via Google News and Bing News